Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma

Completed · Phase 4

Conditions studied: Melasma

In brief

To determine the effectiveness and safety of sequential therapy with of Tri-Luma® Cream and a series of Glycolic Acid peels in treatment of moderate to severe melasma.

Key facts

Study ID

NCT00472966

Run by

Galderma R&D

People needed

20

Starts

2006-11-01

Expected to finish

2007-04-01

Last updated by the study team

2022-07-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects diagnosed with moderate to severe melasma

You may not qualify if…

• Subjects under treatment for a dermatologic condition, which may interfere with the safe evaluation of the study combination (e.g. eczema, psoriasis, severe sun-damage, dermatitis)
• Subjects with a diagnosis of skin cancer (BCE, SCC, Melanoma) in the areas to be treated

Where it is running

• Skin Care Research, Inc. — Boca Raton, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.